Insider Transactions in Q3 2021 at Albireo Pharma, Inc. (ALBO)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2021
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
451
-1.7%
|
$14,432
$32.05 P/Share
|
|
Sep 17
2021
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,760
-11.34%
|
$225,040
$29.61 P/Share
|
|
Sep 17
2021
|
Ronald Harold Wilfred Cooper President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,973
+14.89%
|
$227,487
$19.19 P/Share
|
|
Jul 23
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
223
-2.83%
|
$6,913
$31.43 P/Share
|
|
Jul 22
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
90
-1.13%
|
$3,060
$34.13 P/Share
|
|
Jul 22
2021
|
Patrick Taylor Horn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
90
-0.72%
|
$3,060
$34.13 P/Share
|
|
Jul 13
2021
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
98
-0.77%
|
$3,430
$35.02 P/Share
|